A novel microdeletion of 14q13.1q13.3 was identified in a patient with developmental delay and intractable epilepsy. The 2.2-Mb deletion included 15 genes, of which TULIP1 (approved gene symbol: RALGAPA1)was the only gene highly expressed in the brain. Western blotting revealed reduced amount of TULIP1 in cell lysates derived from immortalized lymphocytes of the patient, suggesting the association between TULIP1 haploinsufficiency and the patient's phenotype, then 140 patients were screened for TULIP1 mutations and four missense mutations were identified. Although all four missense mutations were common with parents, reduced TULIP1 was observed in the cell lysates with a P297T mutation identified in a conserved region among species. A full-length homolog of human TULIP1 was identified in zebrafish with 72% identity to human. Tulip1 was highly expressed in zebrafish brain, and knockdown of which resulted in brain developmental delay. Therefore, we suggest that TULIP1 is a candidate gene for developmental delay.
Submicroscopic chromosomal aberrations are considered to comprise up to 15% of all mutations underlying monogenic diseases [1] . Microarray-based comparative genomic hybridization (aCGH) has accelerated to identify such submicroscopic genomic alterations, and many new microdeletion syndromes have been established [2] . Whereas interstitial deletion of 14q13 is rare and only a few patients have been reported. By use of aCGH analyses, we identified a unique 14q13.1q13.3 microdeletion in a patient with developmental delay and intractable epilepsy. Of the 15 genes identified in the microdeletion region, TULIP1 (approved gene symbol: RALGAPA1)was the only one known to be predominantly expressed in normal brain tissue [3] . To evaluate the contribution of TULIP1 to the patient's neurological symptoms, zebrafish embryos with morpholino knockdown system was used as a model organism [4] . Our results suggest that TULIP1 is a candidate gene for developmental delay and epilepsy.
Results

Molecular cytogenetic analyses of 14q13.1q13.3 deletion
For patient 1 (P1), a 2.2-Mb microdeletion of 14q13.1q13.3 (33,462,439//35,694,522) was identified using aCGH ( Fig. 1) . Twocolor fluorescent in situ hybridization (FISH) analysis confirmed the deletion of 14q13.1q13.3 by the loss of the RP11-26M6 and RP11-35M15 signals ( Fig. 2A) . Retrospective evaluation of chromosomal Gbanding previously provided normal karyotype showed reasonable finding with loss of white band (Fig. 2B ). FISH analysis using the same probes revealed that both parents lacked the deletion (data not shown), which indicated de novo deletion in P1. The final karyotype was arr cgh 14q13.1q13.3(33,462,439-35,694,522) × 1.ish(RP11-557O15+,RP11-26M6−,RP11-35M15−,RP11-81F13+,RP11-112H5+) de novo.
To confirm the biological parent-child relationships, microsatellite marker analysis was performed on P1 family members. The results sufficiently verified the biological relationships in this family (Supplementary Table 1 ) and revealed that P1 had only one peak of D14S70, which is within the deletion region; this peak was common only with the mother and there was no common peak of D14S70 with the father (Fig. 2C ). These data indicated that the paternally derived allele at this locus was deleted in P1.
Detailed clinical phenotype of P1
At the time of the study, P1 was a 7-year-old girl. Her birth weight was 3038 g and her head circumference at birth was 36 cm; there were no documented neonatal events. At 2 months, she suffered a seizure that continued for a couple of minutes; at that time she opened her eyes and both eyes and arms moved upward and were fixed. Because similar seizures occurred three times during the next 2 h, she was hospitalized. Brain computed tomography (CT) scan and electroencephalography (EEG) revealed no abnormalities. Seizures were refractory to epilepsy medication and occurred a couple of times per day. Similar to West syndrome, her seizures were composed of a series of attacks and occurred once a week after the patient reached 3 months of age.
When she was 9 months old, P1 was referred to our institution for treatment of the intractable seizures. There were no dysmorphic features. At that time, she was alert but her reaction to her surroundings was poor. Her eyes could not follow a moving target. Hypotonia was obvious but muscle power was enough to move against gravity. There was no symptom of cranial nerve damage. Tonic convulsions with eye movements and upward movement of the arms were observed intermittently. Blood screening tests, including those for inborn error of metabolism, revealed no abnormalities. The EEG showed a diffuse θ wave and a high voltage θ burst during brief tonic seizures ( Supplementary Fig. 1A ). However, there were no paroxysmal findings in intermittent phases. Brain magnetic resonance imaging (MRI) showed mild brain atrophy ( Supplementary Fig. 1B and C). Brain single photon emission computed tomography (SPECT) showed no areas of hypoperfusion (data not shown). The results from other electrophysiological examinations, including auditory brain response (ABR), visual evoked potential (VEP), somato-sensory evoked potential (SSEP), conduction velocity (MCV), and sensory verve conduction velocity (SCV), were within normal limits (data not shown). Conventional chromosomal examination at 9 months of age indicated a normal female karyotype with 46,XX. At 5 years of age, her developmental level was evaluated using the Enjoji Scale of Infant Analytical Development (ESID) and her developmental quotient was determined to be 32 [5] .
TULIP1 screening of additional patients with neurological disorders
Information regarding the genes within the deletion region of P1 was accumulated from the UCSC genome browser (http://www. genome.ucsc.edu/); 15 genes were identified in the 2.8-Mb deleted region (Fig. 1) . Among the 15 genes, TULIP1 was the only gene known to be predominantly expressed in the brain. Thus, TULIP1 was examined as the candidate gene responsible for the clinical symptoms of P1.
Sequence analysis of the entire coding region of TULIP1, which contains 41 exons, was performed using originally accumulated 40 patients' samples and the 100 research resource samples. Four individual missense mutations were identified ( Supplementary  Fig. 2 ). Patient 2 (P2) had a c.889CNA nucleotide alteration in exon 9, which is predicted to result in a P297T amino acid substitution. This proband's father had the same alteration. Patient 3 (P3) and his father had a c.1055ANG (D352G) mutation in exon 10. Patient 4 (P4) and her mother had a c.1531GNA (A511T) mutation in exon 12. Patient 5 (P5) and his father had a c.3132TNG (F914C) mutation. Thus, all of the four missense mutations were inherited from healthy parents. Each of the identified missense mutations was negative in 200 normal controls. The entire coding region of TULIP1 remaining allele of P1 was sequenced and was wild type.
P2 presented with severe mental retardation and intractable epilepsy derived from bilateral perisylvian polymicrogyria. P4 suffered West syndrome in infancy, and manifested intractable epilepsy and moderate mental retardation. P3 and P5 showed moderate mental retardation, but no epilepsy (their family trees are shown in Supplementary Fig. 3 ).
Analysis of TULIP1 expression
Western blotting using polyclonal rabbit anti-TULIP1 antibody was performed and reduced TULIP1 levels were confirmed in immortalized lymphocytes lysates from P1 and P2 (Fig. 3) .
Identification of zebrafish tulip1
In zebrafish, a homolog of human TULIP1 was previously predicted according to genomic information, but the gene has not yet been isolated. Therefore, we cloned and sequenced the cDNA encoding tulip1 from zebrafish. Using RT-PCR, we identified two splice variants of tulip1, tulip1.1 and tulip1.2, which sequences were deposited into GenBank (accession AB476643 and AB476644). The shorter variant (tulip1.1) consisted of 6201-bp and encoded a 2066-residue protein, and the longer variant (tulip1.2) was 6318-bp and encoded a 2105 residue protein. Information from the zebrafish genomic map revealed that zebrafish tulip1 was on chromosome 17 and consisted of 41 exons. In addition, two splicing variants were identified based on alternate usage of exon 40. Although the tulip1.2 variant lacks exon 40, this variant is longer than tulip1.1 because exon 40 contains a stop codon. This exon-intron structure and alternative splicing of exon 40 are common to human and mouse TULIP1 [3] , suggesting that tulip1 is conserved through vertebrate evolution.
The deduced zebrafish Tulip1.1 and Tulip1.2 protein sequences exhibited 72% identity to the corresponding splicing variants from both human and mouse, and the zebrafish splice variants each contained a Rap/Ran-GAP domain (aa 1848-aa 2027), two putative transmembrane domains (aa 1184-aa1206, aa 1370-aa1392), two putative coiled-coil motifs (aa 10-aa 37, aa 1738-aa 1770) and one leucine zipper motif (aa 1074-aa 1088), all of which are also found in human and mouse TULIP1 proteins at the same positions [3] . Collectively, these results suggested that zebrafish tulip1.1 and tulip1.2 are structural and functional homologs of human TULIP1.
To carry out tulip1 knockdown in zebrafish using morpholino antisense oligos, precise 5′ UTR nucleotide sequence information was needed. Thus, we performed 5′ RACE to determine the sequence of the tulip1 5′ UTR in our zebrafish strain. Based on the obtained sequence of a 64-nucleotide fragment immediately upstream of the translational initiation site, the residue at the 5′ terminus of this sequence was guanine, whereas the residue of the position in the genomic database was cytosine. This nucleotide alteration was supposed to be the result of m7G 5′ cap structure. Therefore, this fragment means to be a full length of the 5′ UTR.
Spatial expression patterns of tulip1 during zebrafish embryonic development
To determine the spatial expression pattern of tulip1 in zebrafish, whole-mount in situ hybridization of tulip1 mRNA was performed. At the two-cell stage, tulip1 mRNA was distributed throughout the two blastomeres ( Fig. 4A ), indicating that this mRNA was deposited maternally. At the shield stage, after the launch of zygotic gene expression, tulip1 mRNA was expressed equally in whole blastomeres ( 
Gene knockdown of tulip1 causes severe developmental retardation of the brain
To investigate whether tulip1 is involved in brain development, we performed gene knockdown of tulip1 in zebrafish using morpholino antisense oligos (MO). At 72 h post-fertilization (hpf), tulip1 MO1-injected embryos (Fig. 4J ) exhibited hypomorphic heads compared to wild type or control MO-injected embryos (Figs. 4H-I), whereas trunk development was relatively normal. In addition, approximately half of all morphants had an enlarged pericardium and increased yolk extension thickness (see representative morphant; Fig. 4J ). To investigate whether these defects were caused by the gene-specific knockdown of tulip1 or not, tulip1 MO2, which is another morpholino antisense oligo and non-overlapping with tulip1 MO1, was used. Microinjection of tulip1 MO2 did not give rise to an enlarged pericardium and rarely caused thickening of the yolk sac (data not shown). Therefore, the heart and the yolk defects are not specific to tulip1 knockdown. In contrast, tulip1 MO1 and MO2 caused equivalent growth retardation of the head suggesting that this defect was caused by the specific knockdown of tulip1 (Figs. 5A and B) .
Because the externally hypomorphic head in the zebrafish morphants was similar to the abnormality of the brain observed in P1, serial sections of the head were prepared from tulip1 MO-injected zebrafish embryos to examine specific brain morphology aberrations. In the normal zebrafish midbrain, the brain ventricle was positioned on the section that crossed the middle of the eyes at 48 hpf (Fig. 5C ). This ventricle was obstructed around 60 hpf (Fig. 5E ) and completely buried until 72 hpf in wild type (Fig. 4K ) and control MO-injected (Fig.  4M) zebrafish. In the normal zebrafish hindbrain, the rhombic lip at 48 hpf was thin and the groove of the medulla oblongata was opened wide (Fig. 5D) . The rhombic lip thickened with progressive embryonic development and, as a result, the groove of the medulla oblongata was almost fully occluded at 72 hpf in wild type (Fig. 4L ) and control MOinjected (Fig. 4N) zebrafish. In contrast, in tulip1 MO-injected embryos, the brain ventricle in the midbrain at 72 hpf was unobstructed (Fig. 4O) . Similarly, a thin rhombic lip and widely opened groove of the medulla oblongata was observed in the hindbrain at 72 hpf (Fig. 4P) . These results indicated that the development of the brain in tulip1 MO-injected embryos at 72 hpf ( Whole-body developmental delay was less severe than brain developmental delay; tulip1 MO-injected embryos at 72 hpf were clearly as progressed as wild type embryos at 60 hpf (Fig. 5G) . Collectively, these results indicated that gene knockdown of tulip1 caused severe and specific brain developmental delay.
Discussion
Using aCGH, we identified a previously uncharacterized chromosomal deletion of 14q13.1q13.3 in a female patient with developmental delay and intractable epilepsy. Familial analysis indicated that the deletion occurred de novo. In the literature, there are at least 19 reported cases with deletions near 14q13, and the deletion identified in the present patient (P1) is the smallest among them (Fig. 6) [6] [7] [8] [9] [10] [11] [12] [13] . Clinical findings of available 10 of these previously reported cases are summarized in Table 1 . The common manifestations of the 14q13.2 deletion are developmental delay and mild microcephaly (Table 1 ). In the 2.2-Mb deletion in P1, 15 genes are included according to the 2006 build (Fig. 1) . Schwarzbraun et al. considered TULIP1 as the candidate gene for the neurological phenotypes of deletion 14q13, and analyzed the genomic structure and the function [3] . According to the study, TULIP1 was expressed ubiquitously in pre-and postnatal human tissues. The nucleotide sequence of TULIP1 was predicted to encode Rap-Gap domains [3] , which is also contained in TSC2, one of the genes responsible for tuberous sclerosis. Since haploinsufficiency of TSC2 can affects neurological functions [3] , Schwarzbraun et al. analyzed the sequence of TULIP1 in a family with idiopathic basal ganglia calcification (IBGC; Fahr disease), but found no association between TULIP1 mutation and idiopathic basal ganglia calcification. Whereas, the similarities between TULIP1 and TSC2 led us to hypothesize that TULIP1 might be associated with the idiopathic developmental delay and epilepsy. In the present study, reduced TULIP1 levels were observed in cell lysates from immortalized lymphocytes derived from P1 (Fig. 3) . Subsequent mutation analyses identified no TULIP1 mutation on the remaining allele. This evidence indicates that TULIP1 expression is allele-dose dependent, making TULIP1 a credible candidate gene for the phenotype of P1. We therefore analyzed the entire TULIP1 coding region from 140 subjects with developmental delay and/or epilepsy. From this second screening, four individual TULIP1 missense mutations were identified in four patients (Supplementary Fig. 2 ), and two of them were located within conserved sequence region among mammalian species (Supplementary Fig. 4 ). However, all four missense mutations were inherited from their healthy parents ( Supplementary Figs. 2 and 3) .
To confirm whether TULIP1 deletion influenced the phenotypic appearance of P1, we used a zebrafish knockdown system in which expression of the zebrafish homolog of TULIP1 was artificially depressed. We first identified and sequenced the full-length cDNA of zebrafish tulip1 including the 5′ and 3′ UTRs; the zebrafish and human sequences shared 72% identity. In situ hybridization revealed that Tulip1 was expressed in the wild type zebrafish forebrain and tulip1 knockdown resulted in brain developmental delay but normal whole body development. These findings are comparable to that observed for P1, who had TULIP1 deletion and manifested severe developmental delay, intractable epilepsy, and mild cerebral atrophy.
Kamnasaran et al. reported six patients associated with holoprosencephaly and common 14q13 microdeletion, which is overlapped with that of the present patient (P1) (Fig. 6) [14] . In spite of common deletions, penetrance of holoprosencephaly was not 100%, which may depend on the parental origin of the deletion. Uniparental disomy of chromosome 14 (UPD14) results in a distinctive phenotype with developmental delay and dysmorphic features depending on the parental origin [15, 16] . Although the imprinting locus of UPD14 is far from the 14q13 locus, we cannot deny the possibility that penetrance of holoprosencephaly is influenced by the allele origin.
As same as this manner, TULIP1 may be influenced by genomic imprinting. Although the missense mutation P297T was shared with P2 and her healthy father, western blotting analyses showed reduced TULIP1 expression in immortalized lymphocyte cell extracts from P2. If TULIP1 was transcribed only from the paternal allele, P2 would only be able to synthesize the mutated protein [17] . The evidence that chromosomal deletion of 14q13.q13.3 in P1 was derived from paternal allele may support this hypothesis. Therefore, we cannot rule out possible pathogenicity of familial missense mutations identified in this study.
Materials and methods
Materials
After informed consent based on the permission of the ethical committee of Tokyo Women's Medical University, peripheral blood samples of 300 patients with idiopathic mental retardation and/or epilepsy of unidentified etiology were accumulated to investigate potential genomic copy number aberrations using aCGH. In some cases of chromosomal aberrations, blood samples were also obtained from both parents of the patient. The samples in which no genomic copy number aberrations were identified were used in the second screening to identify whether gene-specific mutations were present. In this study, 40 samples derived from patients with neurological symptoms including developmental delay and/or epilepsy were used for the second screening. An additional 100 subjects, which were determined by aCGH to be negative for chromosomal aberrations and other known disease-causing mutations, including mutation of FMR1,  AFF2, PQBP1, ARX, MECP2, ATRX, RPS6KA3, IL1RAPL1, TSPAN7, OPHN1,  PAK3, ACSL4, AGTH2, ARHGEF6, GDI1, SLC6A8, FTSJ1, ZNF41 , and DLG3, were provided by the consortium of Research Resource for Mental Retardation supported by the Ministry of Welfare, Labor, and Health of Japan [18] . One hundred DNA samples from peripheral blood lymphocyte of healthy Japanese volunteers and one hundred Caucasian DNA samples (Caucasian Panel of 100 (HD100CAU); Coriell Institute for Medical Research, USA) were also used for the population study.
aCGH analysis
Genomic DNA was extracted from peripheral blood using the QIA quick DNA extraction kit (Qiagen, Hilden, Germany). Genomic copy number aberrations were analyzed using the Human Genome CGH Microarray 105A chip (Agilent Technologies, Santa Clara, CA) according to the method described elsewhere [19] [20] [21] [22] . Briefly, 500 ng patient and reference DNA from healthy Japanese individuals were digested with restriction enzymes, Alu I and RsaI (Promega, Madison, WI). Cy-5 (patient) or Cy-3 dUTP (reference) were incorporated using Klenow fragment. The array was hybridized with labeled patient and reference DNA in the presence of Cot-1 DNA (Invitrogen, Carlsbad, CA) and blocking agents (Agilent Technologies) for 40 h at 65°C, washed and scanned on the scanner (Agilent Technologies). Data was extracted using Agilent Feature Extraction software ver 9 with the default settings for aCGH analysis. Statistically significant aberrations were determined using the ADM-II algorithm in CGH Analytics software version 3.5 (Agilent Technologies). Breakpoints were defined as the start and stop location of the first and last probes, respectively, included in the algorithmically determined region of deletion.
Fluorescence in situ hybridization (FISH) analysis
Metaphase or prometaphase chromosomes were prepared from phytohemagglutinin-stimulated peripheral blood lymphocytes according to standard techniques. FISH analyses were performed using a combination of two BAC clones with the target clone and the marker clone [22] . Briefly, slidemounted chromosomes were hardened at 65°C for 150 min and then denatured in 70% formamide containing 2× standard saline citrate (SSC) at 70°C for 2 min, and then dehydrated at − 20°C in ethanol. 1.5 μg of BAC clone DNA extracted using GenePrepStar PI-80X (Kurabo, Osaka, Japan) was labeled with SpectrumGreen TM-11-dUTP or SpectrumOrange TM-11-dUTP (Vysis, Downers Grove, IL) via nick translation and denatured at 70°C for 5 min in the probe hybridization mixture including 50% of formamide, 2 × SSC, and 10% dextran sulfate. Then, it was applied on the chromosomes, and incubated at 37°C for 16 h. Slides were washed twice in 50% formamide containing 2 × SSC at 43°C for 15 min, 2 × SSC for 5 min, 1 × SSC for 5 min, 0.1% (v/v) Triton X-100/4 × SSC for 5 min with shaking, 4 × SSC for 5 min, then 2 × SSC for 5 min and then mounted in antifade solution (Vector, Burlingame, CA) containing 4′,6-diamino-2-phenylindole (DAPI). Photomicroscopy was performed under a microscope equipped with a quad filter set containing single band excitation filters (Leica Microsystems, Tokyo, Japan).
Microsatellite marker analysis
Familial relationships and the origin of the 14q13.1q13.3 deletion for P1 were analyzed using the PRISM Linkage Mapping Set Panel 20 (Applied Biosystems Inc, Foster City, CA), which includes the primer sets of 14 microsatellite markers D14S261, D14S283, D14S275, D14S70, D14S288, D14S276, D14S63, D14S258, D14S74, D14S68, D14S280, D14S65, D14S985 and D14S292. PCR amplification using True Allele PCR Premix (Applied Biosystems Inc.) was performed according to the manufacture's protocol [23] . Then, the products were separated using the 3130xl Genetic Analyzer (Applied Biosystems Inc.) and analyzed by GeneMapper software (Applied Biosystems Inc.).
Mutation screening of the TULIP1 coding region
All 41 TULIP1 exons from each patient were amplified by PCR using originally designed primers located on the both neighboring intronic sequences (Supplementary Table 2 ) according to the standard method. All amplicons were subjected to direct sequencing using the BigDye Terminator Cycle Sequencing kit (Applied Biosystems Inc.) according to the manufacturer's protocol. Sequencing reactions were separated using a 3130xl Genetic Analyzer (Applied Biosystems Inc.).
Because exon 33 was too large to analyze in the same manner with the other exons, it was divided into several parts. However, primers based on the exonic sequence could not be used for PCR due to the existence of the pseudogene of TULIP1 which had quite similar sequences. When we use the primers on the coding region of exon 33 for PCR amplification, both the true TULP1 and pseudo TULIP1 were amplified. To circumvent this difficulty, the entire exon 33 was PCR amplified by both neighboring intron-based primers, which cannot amplify exon 33 of the pseudogene of TULIP1, and used as a template for direct sequencing using sequential exon-based primers.
Western blotting
Immortalized lymphocytes were collected by centrifugation at 1400 × g and homogenized in sample buffer (50 mM Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate (SDS), and 10% (v/v) glycerol) by sonication. β-Mercaptoethanol and bromophenol blue were added to cell lysates at final concentrations of 6% (v/v) and 0.003%, respectively. Proteins were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes (Immobilon; Millipore, Billerica, MA). Membranes were blocked in phosphate buffered saline (PBS) containing 10% nonfat milk and 0.05% (w/v) Tween 20 for 1 h at room temperature. Membranes were then incubated with rabbit polyclonal anti-GARNL1 (TULIP1) (1:100 dilution, HPA00851; Atlas Antibodies, Sweden) or anti-β-actin monoclonal antibody (1:5000 dilution, A5441; Sigma, MO) overnight at 4°C. Membranes were washed three times in PBS containing 0.05% Tween 20 and then incubated in HRP-conjugated secondary antibody for 1 h at 37°C. Membranes were washed as before and signals were detected using SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL) and FUJI RAS3000 (FUJI Film, Tokyo, Japan).
Zebrafish maintenance
Adult zebrafish (Danio rerio) were maintained at 28.5°C under 14 h light/10 h dark cycle conditions. Embryos from natural crosses were collected a few minutes after spawning and cultured at 28.5°C in water containing 0.006% NaCl and 0.00025% methylene blue. Embryos were staged according to morphology and hours post-fertilization (hpf) as described [4] . For in situ hybridization, N-phenylthiourea was added to culture water at a final concentration of 0.003% to avoid pigmentation of larvae.
Cloning of zebrafish tulip1
The sequence of the zebrafish tulip1 cDNA has been previously predicted using genomic data (GenBank accession XM_679242). In this study, the cDNA corresponding to the open reading frame (ORF) of tulip1 was cloned by reverse transcription-polymerase chain reaction (RT-PCR) using primers designed based on the predicted sequence. Briefly, total RNA was extracted from 14 somite stage embryos using the RNeasy Mini Kit (Qiagen), and cDNA was synthesized using the Omniscript RT Kit (Qiagen) according to the manufacturer's instructions. All PCR amplification reactions were performed using KOD plus DNA polymerase (TOYOBO, Osaka, Japan). The 5′ and 3′ untranslated regions were also cloned by the rapid amplification of cDNA ends (RACE) method using the 5′-RACE Core Set (TAKARA, Otsu, Japan). (The sequences of the primers used in this study are shown in Supplementary Table 3.)
Whole mount in situ hybridization of tulip1 RNA Whole-mount in situ hybridization was performed as described [4] . Briefly, digoxigenin-labeled antisense RNA probes, complementary to four partially overlapping regions of zebrafish tulip1, were synthesized. These probes corresponded to the following regions of tulip1; nt 511-1526, nt 1303-2337, nt 3714-4733 or nt 4527-5644 (relative the transcriptional start site GenBank accession AB476643 and AB476644). Because these four probes displayed identical staining patterns, they were used as a mixture. To enhance the contrast of the signal of tulip1 in shield and bud stage embryos, specimens were soaked in transparency reagent (2:1 mixture of benzyl benzonate/benzyl alcohol).
Morpholino oligos and microinjection
Morpholino antisense oligos (MOs) were purchased from Gene Tools, LLC. The sequences of the two non-overlapping MOs used in this study were as follows: tulip1 MO1, 5′-GAGATGTTTTGAAGAGC-TAATGATA-3′; tulip1 MO2, 5′-TCTTCCGTTAATTCCCTCAAACATG-3′. We also used the following control MO that does not match any zebrafish gene: 5′-AAACGTCTCTTGACTCTCCGCGATG-3′. MOs were dissolved in Danieau solution (5 mM HEPES, pH 7.6, 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , and 0.6 mM Ca(NO 3 ) 2 ) to a final concentration of at 10 μg/μl and stored at −20°C. MOs were microinjected at 3 ng/nl as described [4] .
Preparation of zebrafish head sections
Zebrafish embryos in appropriate stages were fixed in PBS containing 4% paraformaldehyde (PFA) at 4°C overnight. The fixed embryos were gradually dehydrated with ethanol and then completely dehydrated using 2-propanol. Dehydrated embryos were soaked in xylene and embedded following transfer to Paraplast Plus embedding medium (McCormick Scientific, St. Louis, MO) under microscopic observation. Specimens were cut into serial sections (7 μm) and stained using Mayer's hematoxylin and eosin solutions.
